1-7 of 7
Beth Karlan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Open Access
Kelly L. Bolton, Denise Chen, Rosario Corona de la Fuente, Zhuxuan Fu, Rajmohan Murali, Martin Köbel, Yanis Tazi, Julie M. Cunningham, Irenaeus C.C. Chan, Brian J. Wiley, Lea A. Moukarzel, Stacey J. Winham, Sebastian M. Armasu, Jenny Lester, Esther Elishaev, Angela Laslavic, Catherine J. Kennedy, Anna Piskorz, Magdalena Sekowska, Alison H. Brand, Yoke-Eng Chiew, Paul Pharoah, Kevin M. Elias, Ronny Drapkin, Michael Churchman, Charlie Gourley, Anna DeFazio, Beth Karlan, James D. Brenton, Britta Weigelt, Michael S. Anglesio, David Huntsman, Simon Gayther, Jason Konner, Francesmary Modugno, Kate Lawrenson, Ellen L. Goode, Elli Papaemmanuil
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4947–4956.
https://doi.org/10.1158/1078-0432.CCR-21-3817
Published: 14 November 2022
View articletitled, Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Open the PDF for Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes in another window
Includes: Supplementary data
Journal Articles

Abstract A26: Molecular analysis of short- vs. long-term ovarian cancer survivors

Free
Elaine Stur, Graziela Zibetti Dal Molin, Sherry Wu, Keith Baggerly, Shelley Tworoger, Douglas Levine, Beth Karlan, Kathleen Moore, Susan Lutgendorf, Anil Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A26.
https://doi.org/10.1158/1557-3265.OVCA19-A26
Published: 01 July 2020
View articletitled, Abstract A26: Molecular analysis of short- vs. long-term ovarian cancer survivors
Journal Articles

Abstract POSTER-BIOL-1348: No association between PARK2 and BRCA1-associated gynecologic cancers

Free
Christine Walsh, Hoorig Nassanian, Hasmik Agadjanian, Carl Miller, Sandra Orsulic, Beth Karlan
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-BIOL-1348.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-BIOL-1348
Published: 15 August 2015
View articletitled, Abstract POSTER-BIOL-1348: No association between PARK2 and BRCA1-associated gynecologic cancers
Journal Articles

Abstract POSTER-CTRL-1213: Whole exome and targeted resequencing, of population based ovarian cancer cases and controls, identifies susceptibility genes for ovarian cancer

Free
Susan J. Ramus, Honglin Song, Ed Dicks, Maria Intermaggio, Jane Hayward, Jonathan P. Tyrer, Jacek Gronwald, Susanne Krüger Kjær, Alice Wittemore, Beth Karlan, Kunle Odunsi, Usha Menon, David D. Bowtell, Ellen L. Goode, Paul D.P. Pharoah, Simon A. Gayther
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-CTRL-1213.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-CTRL-1213
Published: 15 August 2015
View articletitled, Abstract POSTER-CTRL-1213: Whole exome and targeted resequencing, of population based ovarian cancer cases and controls, identifies susceptibility genes for ovarian cancer
Journal Articles

Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

Free
Francisco J. Candido-dos-Reis, Honglin Song, Ellen L. Goode, Julie M. Cunningham, Brooke L. Fridley, Melissa C. Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington, Susan J. Ramus, Anna de Fazio, Gillian Mitchell, Sian Fereday, Kelly L. Bolton, Charlie Gourley, Caroline Michie, Beth Karlan, Jenny Lester, Christine Walsh, Ilana Cass, Håkan Olsson, Martin Gore, Javier J. Benitez, Maria J. Garcia, Irene Andrulis, Anna Marie Mulligan, Gord Glendon, Ignacio Blanco, Conxi Lazaro, Alice S. Whittemore, Valerie McGuire, Weiva Sieh, Marco Montagna, Elisa Alducci, Siegal Sadetzki, Angela Chetrit, Ava Kwong, Susanne K. Kjaer, Allan Jensen, Estrid Høgdall, Susan Neuhausen, Robert Nussbaum, Mary Daly, Mark H. Greene, Phuong L. Mai, Jennifer T. Loud, Kirsten Moysich, Amanda E. Toland, Diether Lambrechts, Steve Ellis, Debra Frost, James D. Brenton, Marc Tischkowitz, Douglas F. Easton, Antonis Antoniou, Georgia Chenevix-Trench, Simon A. Gayther, David Bowtell, Paul D.P. Pharoah
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (3): 652–657.
https://doi.org/10.1158/1078-0432.CCR-14-2497
Published: 01 February 2015
View articletitled, Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Open the PDF for Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B48: Targeting chemo-resistance in CCNE1-amplified ovarian cancer

Free
Barbie Taylor-Harding, Hasmik Agadjanian, Paul Joseph Aspuria, Takako Mizuno, Dong-Joo Cheon, Sandra Orsulic, Beth Karlan, Christine Walsh, Wolf Ruprecht Wiedemeyer
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): B48.
https://doi.org/10.1158/1078-0432.OVCA13-B48
Published: 13 May 2014
View articletitled, Abstract B48: Targeting chemo-resistance in CCNE1-amplified ovarian cancer
Journal Articles

A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission

Free
Stanley B. Kaye, Louis Fehrenbacher, Robert Holloway, Amnon Amit, Beth Karlan, Brian Slomovitz, Paul Sabbatini, Ling Fu, Robert L. Yauch, Ilsung Chang, Josina C. Reddy
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (23): 6509–6518.
https://doi.org/10.1158/1078-0432.CCR-12-1796
Published: 29 November 2012
View articletitled, A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
Open the PDF for A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission in another window
Includes: Supplementary data